XML 82 R65.htm IDEA: XBRL DOCUMENT v3.25.0.1

Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted Average Assumptions of Stock Options

The following table sets forth the weighted-average assumptions used at the respective grant dates to determine the fair values of the Company’s stock option awards granted during the years ended December 31, 2024, 2023 and 2022.

		Year Ended December 31,
		2024				2023				2022
Risk-free interest rate			4.45	%			4.18	%			1.61	%
Expected term (years)			6.00				6.00				6.00
Volatility			49.02	%			55.63	%			56.71	%
Dividend yield			3.64	%			2.87	%			3.85	%
Fair value per stock option		$	10.28			$	15.36			$	9.89

The following table sets forth the assumptions used at the grant date to determine the fair value of the Company's performance stock option awards granted during the years ended December 31, 2024 and 2023.

		Year Ended December 31,
		2024				2023
Risk-free interest rate			4.43	%			4.13	%
Expected term (years)			6.09				7.00
Volatility			48.91	%			56.32	%
Dividend yield			3.64	%			2.87	%
Fair value per performance stock option (1)		$	10.05			$	14.97

(1)Represents the weighted-average fair value at each point of projected exercise under the Monte Carlo valuation method.

Schedule of Stock Options Activity

The following table sets forth Chemours’ stock option activity for the years ended December 31, 2024, 2023 and 2022.

		Number of Shares (in Thousands)				Weighted-average Exercise Price (per Share)				Weighted-average Remaining Contractual Term (in Years)				Aggregate Intrinsic Value (in Thousands)
Outstanding, December 31, 2021			6,967			$	20.32				6.60			$	101,261
Granted			1,031				25.98
Exercised			(3,041	)			16.76
Forfeited			(202	)			21.29
Expired			(87	)			32.78
Outstanding, December 31, 2022			4,668			$	23.61				7.08			$	42,668
Granted			560				34.82
Exercised			(1,153	)			16.84
Forfeited			(296	)			29.04
Expired			(169	)			39.02
Outstanding, December 31, 2023			3,610			$	26.35				6.51			$	27,760
Granted			705				27.50
Exercised			(453	)			18.23
Forfeited			(290	)			30.01
Expired			(267	)			40.04
Outstanding, December 31, 2024			3,305			$	26.28				6.22			$	3,294
Exercisable, December 31, 2024			2,319			$	25.27				5.12			$	3,307

		Number of Shares (in Thousands)				Weighted-average Exercise Price (per Share)				Weighted-average Remaining Contractual Term (in Years)				Aggregate Intrinsic Value (in Thousands)
Outstanding, December 31, 2022			—			$	—				—			$	—
Granted			239				38.32
Vested			—				—
Forfeited			(64	)			38.32
Expired			—				—
Outstanding, December 31, 2023			175			$	38.32				9.17			$	—
Granted			204				30.25
Vested			—				—
Forfeited			(97	)			37.27
Expired			—				—
Outstanding, December 31, 2024			282			$	32.85				8.97			$	—
Exercisable, December 31, 2024			57			$	38.32				8.17			$	—

Schedule of Restricted Stock Units Activity

The following table sets forth non-vested RSUs at December 31, 2024, 2023 and 2022.

		Number of Shares (in Thousands)				Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2021			1,159			$	22.20
Granted			388				28.08
Vested			(473	)			20.97
Forfeited			(77	)			21.75
Non-vested, December 31, 2022			997			$	25.10
Granted			497				33.22
Vested			(391	)			20.71
Forfeited			(236	)			18.84
Non-vested, December 31, 2023			867			$	30.86
Granted			430				25.02
Vested			(343	)			28.65
Forfeited			(152	)			32.50
Non-vested, December 31, 2024			802			$	28.36

Schedule of Performance Share Units Activity

The following table sets forth non-vested PSUs at 100% of target amounts at December 31, 2024, 2023 and 2022.

		Number of Shares (in Thousands)				Weighted-average Grant Date Fair Value (per Share)
Non-vested, December 31, 2021			755			$	26.72
Granted			316				28.77
Vested			(213	)			43.83
Forfeited			—				—
Non-vested, December 31, 2022			858			$	22.48
Granted			103				40.64
Vested			(410	)			17.14
Forfeited			(158	)			30.63
Non-vested, December 31, 2023			393			$	31.41
Granted			73				32.77
Vested			(103	)			26.68
Forfeited			(272	)			32.84
Non-vested, December 31, 2024			91			$	33.57

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested performance-based units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration